Navigation Links
Animal Rehabilitation and Wellness Center Gives Castle Rock Golden Retriever a Second Chance to Enjoy Life with Stem Cell Therapy

Poway, CA (PRWEB) September 17, 2013

Over the course of last year, Deuce, a five year old Golden Retriever, was being treated by Dr. Cheryl Adams at Animal Rehabilitation and Wellness Center of Castle Pines for pain that had became so severe that he would require pain medication to get around on most days. Dr. Adams turned to stem cell therapy in April to battle Deuce’s pain, and just five months since Deuce’s stem cell therapy his owner, Laura Preston, is happy to report that “He has very few sore days, and I have not seen him be stiff or lame in a few months.”

Deuce was only four when he started to show signs of discomfort in his back legs. As a Golden Retriever, Deuce can be expected to live an average of 11 active and energetic years, but as a youngster he collided with another dog playing on the beach when he lived in warm San Diego. There were no immediate effects from the accident, but his first winter in cold Colorado brought some issues to owner, Laura’s attention.

Deuce was having difficulty getting up from a lying position, walking around the house, or just standing for any length of time. Never mind the fun activities he used to enjoy like long walks in his beautiful home of Castle Rock, Colorado, or enjoying a swim. Dr. Adams and Deuce’s owners refused to allow him to live with such a decreased quality of life at the young age of five.

Dr. Adams collected a small portion of Deuce’s fat, which naturally has stem cells in it, and sent it to Vet-Stem’s lab in San Diego, California. In 48 hours Dr. Adams received a concentrated number of Deuce’s own stem cells for injection into his hocks. Dr. Adams and Deuce’s owners hoped stem cells would improve Deuce’s quality of life by decreasing his pain enough to allow him to stop daily medication and enjoy the activities he used to love so much.

“The first few weeks after stem cells he was like a one year old puppy,” Laura described, “Running and jumping around with no issues.” Slowly increasing Deuce’s movement over time, he was able to return to his full activity level and by three months he had only one noticeably sore day a week. “He can run and swim fine,” Laura states, “All in all he has great improvement!”

Deuce’s veterinarian, Dr. Adams, has been a long-time supporter of stem cell therapy and regenerative medicine in animals. In 2005, Dr. Adams began working with Vet-Stem as a clinical study investigator, and became one of the first credentialed Veterinarians for stem cell treatment. She was involved in the initial small animal clinical studies utilizing autologous, fat derived, stem and regenerative cells to treat orthopedic conditions. She is a published author who in 2007 received an award for Regenerative Stem Cell use in companion animals.

The Animal Rehabilitation and Wellness Center of Castle Pines is proud to be a designated Center of Excellence for Vet-Stem Regenerative Veterinary Medicine, and for their breakthrough work in stem cell therapy. ARWC continues to help with the investigation of the use of stem cell therapy for other diseases such as inflammatory bowel disease (IBS), select neurologic diseases, kidney disease, some liver disease, and atopy (skin allergies), with the goal to achieve optimal wellness and health in companion animals of all ages. ARWC is a referral center committed to helping companion pets recover from illness, injury and surgery.

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine, visit or call 858-748-2004.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. "Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals
2. Animal Biotechnology - Technologies, Markets and Companies
3. Animal Husbandry Equipment Market in United States: Business Report 2011
4. Novel compound halts tumor spread, improves brain cancer treatment in animal studies
5. The Italian Institute of Prophylaxis against Animal Diseases (IZS) to test effectiveness of BeesFree Inc.s Technology in Combating Colony Collapse Disorder
6. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
7. Advanced Animal Diagnostics Adds Sales & Marketing Leadership
8. Isis And Collaborators Alleviate Disease In Animal Models Of Myotonic Dystrophy
9. Pinnaclife, Inc., Announces NDC, Inc., to Exclusively Distribute the New Animal Health Product Line!
10. Pig genome offers insights into the feistiest of farm animals
11. Pinnaclife Animal Health Features Seal N Heal Wound Shield in New Veterinary Dermatologist Tested and Approved Product Line!
Post Your Comments:
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology:
(Date:11/11/2015)... 11, 2015   MedNet Solutions , an innovative SaaS-based ... research, is pleased to announce that it will be a ... event, to be held November 17-19 in ... live demonstrations of iMedNet , MedNet,s easy-to-use, ... iMedNet has been able to deliver time and cost ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):